Animal Vaccines Market - Global Forecast 2026-2032

The Animal Vaccines Market is projected to reach USD 15.53 Billion in 2026. It is expected to continue growing at a CAGR of 6.99%, reaching USD 23.40 Billion by 2032.

The animal vaccines market is becoming a core pillar of veterinary public health, food security, and One Health policy. Vaccination helps reduce morbidity and mortality in livestock, poultry, aquaculture, and companion animals while lowering reliance on antimicrobials and supporting safer movement of animals and animal-derived products.

Demand is being reinforced by rising protein consumption, intensification of livestock production, expansion of pet ownership, and persistent risk from transboundary and zoonotic diseases. Verified public-health agencies such as the CDC note that six in ten known infectious diseases in people can spread from animals, while WOAH emphasizes that animal diseases cause substantial losses to global production systems. These realities keep animal vaccine development, cold-chain distribution, and disease surveillance high on the strategic agenda for veterinarians, producers, regulators, and animal health stakeholders.

Transformative Shifts in the Animal Vaccine Landscape

The animal vaccine landscape is shifting from reactive disease control toward preventive, data-led health management. Producers and veterinarians increasingly prioritize vaccination programs that protect herd and flock productivity, limit outbreak costs, support animal welfare, and improve compliance with trade, residue, and biosecurity standards.

Technology is also reshaping the competitive environment. Conventional inactivated and live attenuated vaccines remain widely used, but recombinant, vector-based, subunit, DNA, and mRNA platforms are gaining attention because they can improve antigen targeting, support differentiated immune responses, and accelerate development cycles. At the same time, regulators are placing stronger emphasis on pharmacovigilance, quality assurance, manufacturing consistency, and demonstrated field effectiveness, raising the bar for manufacturers across the animal health value chain.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the animal vaccines ecosystem by improving how pathogens are detected, antigens are prioritized, and vaccination strategies are deployed. AI-enabled bioinformatics can screen genomic and proteomic data to identify candidate antigens, support epitope mapping, assess virulence markers, and help researchers compare circulating strains with vaccine strains.

Beyond discovery, AI supports outbreak forecasting, cold-chain monitoring, manufacturing quality analytics, pharmacovigilance, and adverse-event signal detection. When integrated with veterinary diagnostics, farm management systems, geospatial data, and epidemiological databases, AI can help companies and public agencies move from calendar-based vaccination to more risk-based immunization planning. The practical impact is faster response, better targeting, stronger compliance, and improved resilience against diseases that threaten animal health and food supply.

Key Regional Insights

Asia-Pacific is a high-priority region due to its large livestock and poultry populations, expanding aquaculture sector, and continued focus on diseases affecting food animals, including avian influenza, foot-and-mouth disease, porcine diseases, and aquatic animal pathogens. China, India, Japan, South Korea, and Australia combine strong domestic demand with different regulatory and production profiles, making localized vaccine portfolios, diagnostic alignment, and distribution capability essential for market access.

North America benefits from advanced veterinary infrastructure, strong companion animal care, established livestock biosecurity programs, and broad use of diagnostics to guide preventive health planning. Europe is shaped by rigorous regulatory oversight, farm-to-fork safety priorities, antimicrobial stewardship, animal welfare standards, and high adoption of preventive veterinary medicine. Latin America, led by Brazil and Mexico, remains important for cattle, poultry, swine, and export-oriented animal protein systems, where vaccination supports productivity, trade continuity, and control of regionally significant infectious diseases.

The Middle East and Africa show rising need for vaccines that address climate-sensitive disease spread, cross-border animal movement, emerging companion animal care, and food security priorities. In these regions, affordability, heat-stable formulations, public procurement, surveillance-linked vaccination campaigns, and last-mile veterinary access are decisive factors for effective immunization coverage and sustainable disease prevention.

Key Group Insights

ASEAN demand is supported by dense poultry and swine production, aquaculture growth, and the need for scalable vaccination to protect protein supply against endemic and emerging diseases. The GCC market is more specialized, with companion animal care, equine health, camel health, and food-security investments influencing procurement, import controls, and distribution strategies across arid and high-temperature environments.

The European Union remains a benchmark for regulatory quality, traceability, antimicrobial-reduction policy, and animal welfare requirements, creating opportunities for vaccines that demonstrate safety, efficacy, consistency, and measurable value in field conditions. BRICS countries represent a broad strategic base because they combine large animal populations, expanding domestic manufacturing capabilities, public-sector disease-control priorities, and increasing emphasis on self-reliant animal health systems.

G7 markets are important for innovation, premium veterinary care, advanced companion animal medicine, and high compliance standards, while NATO countries overlap with many advanced veterinary, food-security, and biosecurity systems. Across these groups, successful companies align product registration, field evidence, pharmacovigilance, supply reliability, and local technical support with disease burdens, species economics, and policy objectives.

Key Country Insights

The United States and Canada are driven by advanced companion animal medicine, commercial livestock vaccination, strong diagnostic networks, and mature veterinary service models, while Mexico and Brazil emphasize vaccines that protect cattle, poultry, swine, and export-oriented production. Brazil’s scale in animal protein gives it strategic importance for regional disease prevention, and Mexico’s integration with North American livestock and poultry trade reinforces the value of reliable vaccination and biosecurity programs.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine high veterinary standards with strong attention to antimicrobial stewardship, animal welfare, traceability, and preventive herd health. Russia’s market reflects large-scale livestock needs, transboundary disease preparedness, and domestic production priorities, making vaccine availability and local adaptation central to animal health planning.

China and India are central to global demand because of their large animal populations, protein consumption, poultry and dairy systems, and government-led disease-control programs. Japan, Australia, and South Korea add high-value opportunities through strict biosecurity, advanced veterinary services, strong disease surveillance, and premium livestock and companion animal segments where quality, safety, and regulatory compliance are essential.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize vaccine portfolios around verified disease burden, species economics, regional biosecurity gaps, and evolving One Health priorities. Investment should focus on platforms that enable faster strain updates, stronger thermostability, consistent manufacturing, and easier administration, especially for poultry, swine, cattle, aquaculture, and companion animals.

Companies should expand partnerships with diagnostic laboratories, veterinary networks, universities, producer groups, and public agencies to link vaccination with surveillance, field evidence, and outbreak preparedness. Digital traceability, AI-supported demand planning, cold-chain visibility, and post-vaccination monitoring can improve service levels and reduce waste. Leaders should also build regulatory agility by generating robust safety, efficacy, quality, and pharmacovigilance data suitable for multiple jurisdictions.

Research Methodology

This executive summary is built on secondary research from authoritative public sources, including veterinary public-health agencies, regulatory bodies, trade organizations, peer-reviewed literature, and recognized animal health institutions. Sources considered include WHO, WOAH, FAO, CDC, USDA, EMA, national veterinary authorities, and publicly available scientific and policy documents.

The analysis applies a triangulated methodology that compares disease epidemiology, species-level demand drivers, vaccination policy, regulatory trends, technology adoption, and regional market conditions. Qualitative insights are validated against observable factors such as livestock production systems, companion animal care trends, outbreak preparedness, antimicrobial stewardship initiatives, animal welfare policy, and animal health innovation activity.

Conclusion

Animal vaccines are moving from a supporting veterinary product category to a strategic tool for food security, public health, animal welfare, and sustainable animal production. The market’s long-term relevance is supported by disease prevention needs, antimicrobial stewardship, companion animal humanization, cross-border disease preparedness, and innovation in vaccine platforms.

Companies that combine scientific credibility, region-specific portfolios, reliable manufacturing, regulatory discipline, and digital intelligence will be best positioned to compete. As One Health priorities intensify, animal vaccination will remain essential for reducing disease risk, protecting animal welfare, and strengthening resilient global protein supply chains.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Vaccines Market, by Product

7.1. Introduction
7.2. Inactivated Vaccines
7.3. Live Attenuated Vaccines
7.4. mRNA Vaccines
7.5. Recombinant Vaccines
7.6. Subunit Vaccines

8. Animal Vaccines Market, by Animal Type

8.1. Introduction
8.2. Companion Animals
8.2.1. Cats
8.2.2. Dogs
8.3. Livestock Animals
8.3.1. Cattle
8.3.2. Poultry
8.3.3. Sheep
8.3.4. Swine

9. Animal Vaccines Market, by Disease Type

9.1. Introduction
9.2. Bacterial Infections
9.2.1. Clostridial
9.2.2. E. Coli
9.2.3. Leptospirosis
9.2.4. Pasteurella
9.3. Fungal Infections
9.4. Parasitic Infections
9.4.1. Ectoparasites
9.4.2. Endoparasites
9.5. Viral Infections
9.5.1. Avian Influenza Virus
9.5.2. Bovine Viral Diarrhea Virus (BVDV)
9.5.3. Foot-and-Mouth Disease Virus (FMDV)
9.5.4. Newcastle Disease Virus
9.5.5. Porcine Reproductive & Respiratory Syndrome Virus (PRRSV)
9.5.6. Rabies Virus

10. Animal Vaccines Market, by Route of Administration

10.1. Introduction
10.2. Injectable Vaccines
10.2.1. Intramuscular (IM)
10.2.2. Intravenous (IV)
10.2.3. Subcutaneous (SC)
10.3. Oral Vaccines

11. Animal Vaccines Market, by Distribution Channel

11.1. Introduction
11.2. Online Pharmacies
11.3. Retail Pharmacies
11.4. Veterinary Clinics

12. Animal Vaccines Market, by Region

12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa

13. Animal Vaccines Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Animal Vaccines Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Biogénesis Bagó S.A.
16.2. BioVaxys Technology Corporation
16.3. Boehringer Ingelheim International GmbH
16.4. Brilliant Bio Pharma Private limited
16.5. Ceva Santé Animale
16.6. China Animal Husbandry Industry Co., Ltd.
16.7. Dalan Animal Health
16.8. Elanco Animal Health Inc.
16.9. Endovac Animal Health, LLC by Immvac Inc.
16.10. Hester Biosciences Limited
16.11. HIPRA, S.A.
16.12. Indian Immunologicals Limited
16.13. Kemin Industries, Inc.
16.14. Merck KGaA
16.15. Neogen Corporation
16.16. Phibro Animal Health Corporation
16.17. SAN Vet Holding GmbH
16.18. Sanofi S.A.
16.19. Seppic S.A.
16.20. Torigen Pharmaceuticals Inc.
16.21. Vaxxinova GmbH
16.22. VEROVACCiNES GmbH
16.23. Vetigenics, LLC
16.24. Vetoquinol SA
16.25. Virbac, Inc.
16.26. Zoetis Inc.

List of Figures

FIGURE 1. GLOBAL ANIMAL VACCINES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANIMAL VACCINES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANIMAL VACCINES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANIMAL VACCINES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MRNA VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MRNA VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MRNA VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SHEEP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CLOSTRIDIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CLOSTRIDIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CLOSTRIDIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL E. COLI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL E. COLI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL E. COLI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PASTEURELLA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PASTEURELLA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PASTEURELLA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ECTOPARASITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ECTOPARASITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ECTOPARASITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ENDOPARASITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ENDOPARASITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ENDOPARASITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL AVIAN INFLUENZA VIRUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL BOVINE VIRAL DIARRHEA VIRUS (BVDV) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL FOOT-AND-MOUTH DISEASE VIRUS (FMDV) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL NEWCASTLE DISEASE VIRUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL RABIES VIRUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL RABIES VIRUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL RABIES VIRUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL INJECTABLE VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL INTRAMUSCULAR (IM) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL INTRAVENOUS (IV) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL SUBCUTANEOUS (SC) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ORAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ORAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL ORAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 156. EUROPE ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. EUROPE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 158. EUROPE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 159. EUROPE ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 160. EUROPE ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 161. EUROPE ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 162. EUROPE ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 163. EUROPE ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 164. EUROPE ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 165. EUROPE ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 166. EUROPE ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 167. EUROPE ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 180. AFRICA ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 182. AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 183. AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 184. AFRICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 185. AFRICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 186. AFRICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 187. AFRICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 188. AFRICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 189. AFRICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 190. AFRICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 191. AFRICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. ASEAN ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. ASEAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 195. ASEAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 196. ASEAN ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 197. ASEAN ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 198. ASEAN ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 199. ASEAN ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 200. ASEAN ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 201. ASEAN ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 202. ASEAN ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 203. ASEAN ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 204. ASEAN ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. GCC ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. GCC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 207. GCC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 208. GCC ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 209. GCC ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 210. GCC ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 211. GCC ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 212. GCC ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 213. GCC ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 214. GCC ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 215. GCC ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 216. GCC ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 229. BRICS ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. BRICS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 231. BRICS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 232. BRICS ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 233. BRICS ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 234. BRICS ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 235. BRICS ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 236. BRICS ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 237. BRICS ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 238. BRICS ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 239. BRICS ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 240. BRICS ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 241. G7 ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. G7 ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 243. G7 ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 244. G7 ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 245. G7 ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 246. G7 ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 247. G7 ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 248. G7 ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 249. G7 ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 250. G7 ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 251. G7 ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 252. G7 ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 253. NATO ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 254. NATO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 255. NATO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 256. NATO ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 257. NATO ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 258. NATO ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 259. NATO ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 260. NATO ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 261. NATO ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 262. NATO ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 263. NATO ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 264. NATO ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 265. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 272. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 273. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 274. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 275. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 276. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 277. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 278. CANADA ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. CANADA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 280. CANADA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 281. CANADA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 282. CANADA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 283. CANADA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 284. CANADA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 285. CANADA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 286. CANADA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 287. CANADA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 288. CANADA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 289. CANADA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 290. MEXICO ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. MEXICO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 292. MEXICO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 293. MEXICO ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 294. MEXICO ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 295. MEXICO ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 296. MEXICO ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 297. MEXICO ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 298. MEXICO ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 299. MEXICO ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 300. MEXICO ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 301. MEXICO ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 304. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 305. BRAZIL ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 306. BRAZIL ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 307. BRAZIL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 308. BRAZIL ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 309. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 310. BRAZIL ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 311. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 312. BRAZIL ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 313. BRAZIL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 326. GERMANY ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. GERMANY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 328. GERMANY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 329. GERMANY ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 330. GERMANY ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 331. GERMANY ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 332. GERMANY ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 333. GERMANY ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 334. GERMANY ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 335. GERMANY ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 336. GERMANY ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 337. GERMANY ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 338. FRANCE ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 339. FRANCE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 340. FRANCE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 341. FRANCE ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 342. FRANCE ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 343. FRANCE ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 344. FRANCE ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 345. FRANCE ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 346. FRANCE ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 347. FRANCE ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 348. FRANCE ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 349. FRANCE ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 350. RUSSIA ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 351. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 352. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 353. RUSSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 354. RUSSIA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 355. RUSSIA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 356. RUSSIA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 357. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2017-2032 (USD MILLION)
TABLE 358. RUSSIA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2017-2032 (USD MILLION)
TABLE 359. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 360. RUSSIA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2017-2032 (USD MILLION)
TABLE 361. RUSSIA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 362. ITALY ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 363. ITALY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 364. ITALY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 365. ITALY ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 366. ITALY ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK AN

Companies Mentioned

Biogénesis Bagó S.A.
BioVaxys Technology Corporation
Boehringer Ingelheim International GmbH
Brilliant Bio Pharma Private limited
Ceva Santé Animale
China Animal Husbandry Industry Co., Ltd.
Dalan Animal Health
Elanco Animal Health Inc.
Endovac Animal Health, LLC by Immvac Inc.
Hester Biosciences Limited
HIPRA, S.A.
Indian Immunologicals Limited
Kemin Industries, Inc.
Merck KGaA
Neogen Corporation
Phibro Animal Health Corporation
SAN Vet Holding GmbH
Sanofi S.A.
Seppic S.A.
Torigen Pharmaceuticals Inc.
Vaxxinova GmbH
VEROVACCiNES GmbH
Vetigenics, LLC
Vetoquinol SA
Virbac, Inc.
Zoetis Inc.

Table Information

Report Attribute	Details
No. of Pages	184
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 15.53 Billion
Forecasted Market Value ( USD ) by 2032	$ 23.4 Billion
Compound Annual Growth Rate	6.9%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the Animal Vaccine Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights

Key Group Insights

Key Country Insights

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Veterinary/Animal Vaccines Market - Global Forecast 2026-2032

Companion Animal Vaccine Market - Global Forecast 2026-2032

Companion Animal Vaccines - Global Strategic Business Report

Animal Vaccines Market Size, Share & Trends Analysis Report by Product, Animal, Route of Administration, Distribution Channel, Region, and Growth Forecasts, 2026-2033

Animal Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035